WHO has welcomed the initial clinical trial results from the UK that show “dexamethasone can be lifesaving for critically-ill coronavirus patients”. “This is great news…I congratulate the Government of the UK,” said WHO Director-General Tedros Adhanom Ghebreyesus. Dexamethasone, a low-cost steroid, is the first drug to be shown to improve survival, a chief investigator for the trial said.